2024-09-19 - Analysis Report
## AbbVie Inc (ABBV) Stock Analysis Report

**Company Overview:** AbbVie Inc. is a global biopharmaceutical company focused on developing and marketing treatments for various chronic and life-threatening diseases.

**Performance Analysis:**

* **Outperformance:** ABBV has outperformed the S&P 500 (VOO) by 22.17% in terms of cumulative returns. This represents a relative outperformance of 63.17% compared to its historical performance range. 
* **Recent Price Action:**  The current price of ABBV is $192.75, slightly below the 5-day moving average ($194.26) and 20-day moving average ($195.74) but above the 60-day moving average ($184.27). This suggests a potential short-term consolidation phase.
* **Technical Indicators:**
    * **RSI:** 43.55. The RSI indicates that the stock is currently in neutral territory, suggesting neither overbought nor oversold conditions.
    * **PPO:** -0.5. The PPO indicates a slight negative momentum.
    * **Relative Divergence:**  A recent -5.73% decline in the 20-day relative divergence suggests a short-term downward trend.
    * **Expected Return:**  The expected return is estimated at 23.03%. This represents the potential maximum return over a 5-year period based on current investment amount.
* **Earnings Performance:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-07-25 | 2.65 | 2.57 |
| 2024-04-26 | 2.31 | 2.26 |
| 2024-02-02 | 2.79 | 2.76 |
| 2023-10-27 | 2.95 | 2.86 |
| 2023-07-27 | 2.91 | 2.79 |

ABBV has consistently exceeded earnings expectations over the past few quarters. The most recent quarter (2024-07-25) saw an EPS of $2.65, surpassing the expected EPS of $2.57.  

**Overall Analysis:**

ABBV has outperformed the market in terms of cumulative returns and has a strong track record of exceeding earnings expectations. The recent price action suggests a potential consolidation phase, although technical indicators are neutral. The expected return of 23.03% indicates a potentially attractive investment opportunity. However, it's important to consider the current market conditions and individual risk tolerance before making any investment decisions. 
